Literature DB >> 1768593

Recombinant human erythropoietin: duplicate publication.

B A Warady.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1768593     DOI： 10.1007/bf00857895

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis.

Authors:  F Fabris; I Cordiano; M L Randi; A Casonato; G Montini; G Zacchello; A Girolami
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

2.  Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis.

Authors:  G Montini; G Zacchello; E Baraldi; S Zanconato; A Suppiej; F Fabris; B Andreetta; L Pavanello; F Zacchello
Journal:  J Pediatr       Date:  1990-10       Impact factor: 4.406

3.  Exercise tolerance after anaemia correction with recombinant human erythropoietin in end-stage renal disease.

Authors:  E Baraldi; G Montini; S Zanconato; G Zacchello; F Zacchello
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.